Cystic Fibrosis Patients Sue Medicaid for Refusing Vertex’s CF Drug Kalydeco
A proverbial elephant crowding the drug-accessibility room is getting harder and harder to ignore. The high cost of some new pharmaceutical medicines designed to treat devastating and often deadly, but relatively rare disease conditions, combined with concerns over the sustainability of government-led public health systems and current…